Clinical Trials Logo

Pollen Allergy clinical trials

View clinical trials related to Pollen Allergy.

Filter by:
  • None
  • Page 1

NCT ID: NCT04874714 Terminated - Clinical trials for Perennial Allergic Rhinitis

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

Start date: April 30, 2021
Phase: Phase 3
Study type: Interventional

Prospective, randomized, placebo-controlled, multicenter of 3 active treatment groups, compared to 1 placebo group, for the determination of the efficacy and safety of subcutaneous immunotherapy in patients with mild to moderate asthma and allergic rhinitis/rhinoconjunctivitis (intermittent or persistent) due to hypersensitivity to house dust mites (Dermatophagoides pteronyssinus and / or D. farinae) and grass pollen

NCT ID: NCT04622917 Completed - Allergic Rhinitis Clinical Trials

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

Start date: April 10, 2019
Phase: Phase 4
Study type: Interventional

This study evaluates the effect of intramuscular injected methylprednisolone treating birch pollen induced rhinitis compared to placebo.

NCT ID: NCT03727399 Enrolling by invitation - Pollen Allergy Clinical Trials

Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

Start date: October 1, 2018
Phase:
Study type: Observational

The project examines the hypothesis that monoclonal allergen-neutralizing antibodies can be recombinantly produced from B lymphocytes isolated from pollen allergic patients. Patient samples suitable for antibody cloning are selected based on seroprofiling for the respective allergens. The study aims at isolating lymphocytes from patients with potential allergen-neutralizing IgG in serum and to clone antibodies from antibody gene sequences obtained from B cells of those patients.

NCT ID: NCT01500642 Completed - Pollen Allergy Clinical Trials

Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy

Start date: June 2011
Phase: Phase 3
Study type: Interventional

The dose and the mode of administration of sublingual therapy remain open questions to determine the efficacy and safety of this desensitization therapy, the main purpose of this study is to evaluate if different routes of administration (oral-vestibular vs. sublingual) and a maximum dose of allergen administered are able to determine a different effect or a different incidence of side effects of the therapy in a group of patients with rhinoconjunctivitis and/or asthma due to ragweed

NCT ID: NCT00263627 Completed - Pollen Allergy Clinical Trials

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The aim of this clinical trial is to show safety and efficacy of the allergoid preparation of birch pollen allergens in the treatment of birch allergic patients in a representative number of patients.